Ann Arbor company’s database licensed by AstraZeneca
Multi-national pharmaceutical company AstroZeneca has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.
Multi-national pharmaceutical company AstroZeneca has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.
Minimally invasive procedure is safer for many patients. Not convinced? Why not check it out onlive... live!
Starting next year, the University of Michigan will invest nearly $42.9 million in the university health system's medical imaging project.
The University of Michigan's $2.5 billion "Michigan Difference Campaign" proves that UofM isn't one of the country's largest endowments for nothing.
Our Partners